Caribou Biosciences (CRBU) Shares Issued (2020 - 2026)
Caribou Biosciences (CRBU) reported Shares Issued of $468000.0 for Q1 2026, down 37.18% quarter-over-quarter from $745000.0 in Q4 2025.
Caribou Biosciences (CRBU) Shares Issued (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 6 years of Shares Issued data on file, last reported at $468000.0 in Q1 2026.
- Shares Issued for Q1 2026 came in at $468000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 68.6% YoY), and the FY2025 annual result was $745000.0, down 95.1% from the prior year.
- Shares Issued fell to $468000.0 in Q1 2026 per CRBU's latest filing, from $745000.0 in the prior quarter.
- Over five years, Shares Issued peaked at $17.5 million in Q2 2023 and troughed at -$1.0 million in Q4 2023.
- A 4-year average of $4.7 million and a median of $745000.0 in 2025 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2024 and 2025: Shares Issued jumped 483.61% in 2024, then slumped 80.71% in 2025.
- A 4-year view of Shares Issued shows it stood at -$1.0 million in 2023, then jumped by 483.61% to $3.9 million in 2024, then tumbled by 80.71% to $745000.0 in 2025, then tumbled by 37.18% to $468000.0 in 2026.
- Business Quant data shows CRBU's Shares Issued at $468000.0 in Q1 2026, $745000.0 in Q4 2025, and $3.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26,927.15 |
| 10 | Caribou Biosciences | 177.34 Mn | 59.72 Mn | - | 468,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 468,000.00 |
| Mar 31, 2026 | 468,000.00 |
| Dec 31, 2025 | 745,000.00 |
| Dec 31, 2025 | 745,000.00 |
| Dec 31, 2024 | 3.86 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Mar 31, 2024 | 11.33 Mn |
| Mar 31, 2024 | 11.33 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | 252,000.00 |
| Sep 30, 2023 | 252,000.00 |
| Jun 30, 2023 | 17.50 Mn |
| Jun 30, 2023 | 17.50 Mn |
| Sep 30, 2021 | 319.89 Mn |
| Sep 30, 2021 | 319.89 Mn |
| Dec 31, 2020 | 110,000.00 |
| Dec 31, 2020 | 110,000.00 |
| Sep 30, 2020 | 139,000.00 |
| Sep 30, 2020 | 139,000.00 |